Consort Medical plc Plans Dividend of GBX 7.44 (CSRT)
Consort Medical plc (LON:CSRT) declared a dividend on Tuesday, December 5th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, January 18th will be given a dividend of GBX 7.44 ($0.10) per share on Friday, February 16th. This represents a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 18th. The official announcement can be seen at this link.
Consort Medical (LON CSRT) opened at GBX 1,174 ($15.92) on Friday. The firm has a market cap of $578.56 and a P/E ratio of 2,935.00. Consort Medical has a one year low of GBX 965 ($13.09) and a one year high of GBX 1,220 ($16.54).
A number of equities analysts have recently commented on CSRT shares. Shore Capital reissued a “buy” rating on shares of Consort Medical in a research note on Tuesday, December 5th. N+1 Singer downgraded shares of Consort Medical to a “hold” rating in a research note on Tuesday, December 5th. Numis Securities raised their target price on shares of Consort Medical from GBX 1,084 ($14.70) to GBX 1,144 ($15.51) and gave the company a “hold” rating in a research note on Wednesday, December 6th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a GBX 1,250 ($16.95) target price on shares of Consort Medical in a research note on Thursday, November 9th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of GBX 1,188.17 ($16.11).
TRADEMARK VIOLATION NOTICE: “Consort Medical plc Plans Dividend of GBX 7.44 (CSRT)” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/13/consort-medical-plc-plans-dividend-of-gbx-7-44-csrt.html.
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.